These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29901191)

  • 1. E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Chen J; Gong C; Mao H; Li Z; Fang Z; Chen Q; Lin M; Jiang X; Hu Y; Wang W; Zhang X; Chen X; Li H
    Int J Oncol; 2018 Aug; 53(2):567-578. PubMed ID: 29901191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.
    Cao H; Zhang J; Liu H; Wan L; Zhang H; Huang Q; Xu E; Lai M
    Oncotarget; 2016 Sep; 7(38):61183-61198. PubMed ID: 27533463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol prevents IL-13-induced epithelial-mesenchymal transition in human colorectal cancer cells.
    Xu K; Tao W; Su Z
    Cell Biol Int; 2018 Aug; 42(8):985-993. PubMed ID: 29569786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
    Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.
    Wang T; Chen X; Qiao W; Kong L; Sun D; Li Z
    BMC Cancer; 2017 Nov; 17(1):719. PubMed ID: 29115924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.
    Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
    J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
    Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
    Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
    Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
    Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
    Sakuma K; Sasaki E; Hosoda W; Komori K; Shimizu Y; Yatabe Y; Aoki M
    Cancer Sci; 2021 Sep; 112(9):3846-3855. PubMed ID: 34286904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
    Shen X; Ye Z; Wu W; Zhao K; Cheng G; Xu L; Gan L; Wu Y; Yang Z
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34109988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.